Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348

Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects

NCT02007941 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

NCT04952506 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

NCT04906798 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

NCT04906785 ·Status: UNKNOWN ·Phase: PHASE1

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers

NCT04867200 ·Status: UNKNOWN ·Phase: PHASE1

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344

NCT04673695 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability and PK of SK-08

NCT07021157 ·Status: RECRUITING ·Phase: PHASE1

CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis

NCT03428594 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment

NCT04859439 ·Status: COMPLETED ·Phase: PHASE1

Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)

NCT04678505 ·Status: TERMINATED ·Phase: PHASE1

A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)

NCT06814119 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects

NCT05948059 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis

NCT05099445 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects

NCT03235375 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease

NCT06248567 ·Status: COMPLETED ·Phase: PHASE1

Medicine-induced Cardiac Hemodialysis on COVID-19

NCT05711810 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105

NCT03043482 ·Status: COMPLETED ·Phase: PHASE1

Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study

NCT05407389 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3

A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney Function

NCT05094934 ·Status: TERMINATED ·Phase: PHASE1

A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780

NCT06592482 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment

NCT04527328 ·Status: COMPLETED ·Phase: NA

Pharmacokinetics in Subjects With Renal Impairment

NCT01504165 ·Status: COMPLETED ·Phase: PHASE1

A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers

NCT01578928 ·Status: COMPLETED ·Phase: PHASE1

An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients

NCT01590823 ·Status: COMPLETED ·Phase: PHASE1

A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.

NCT00721422 ·Status: TERMINATED ·Phase: PHASE1